Login / Signup

Covalent PROTAC design method based on a sulfonyl pyridone probe.

Qinhong LuoYaqi WangZhanfeng HouHuiting LiangLicheng TuYun XingChuan WanJianbo LiuRui WangLizhi ZhuWei HanJianlong WuFei LuFeng YinZigang Li
Published in: Chemical communications (Cambridge, England) (2023)
Covalent proteolysis-targeting chimeras (PROTACs) offer enhanced selectivity, prolonged action, and increased efficacy against challenging target proteins. The conventional approach relies on covalent ligands, but our study presents an innovative method employing an N -sulfonyl pyridone warhead to selectively target tyrosine (Tyr) residues. The von Hippel-Lindau (VHL) moiety is transferred from the warhead to the exposed Tyr, allowing us to design a STING degrader (DC 50 0.53 μM, D max 56.65%). This approach showcases the potential of nucleophilic amino acid labeling probes, particularly for proteins lacking easily accessible cysteine residues, opening new possibilities for covalent PROTAC design and targeted protein degradation therapies.
Keyphrases
  • amino acid
  • living cells
  • cancer therapy
  • small molecule
  • fluorescent probe
  • drug delivery
  • single molecule
  • quantum dots
  • human health